CRP and Brain atrophy: Despite these limitations, the current study demonstrates that epigenetic proxies of CRP and GDF15 exposure reflect the activation of immune/inflammation‐related pathways associated with accelerated brain atrophy, cognitive decline, and long‐term dementia risk.